BTIG analyst Timothy Chiang reiterated a Neutral rating on Teva Pharma (NYSE: TEVA) after Momenta (NASDAQ: MNTA) announced that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE